CSL has received approval from the European Commission (EC) for Andembry (garadacimab) to prevent recurrent attacks of ...

CSL Seqirus, the vaccination segment, was affected by low influenza vaccination rates in the US, dragging down overall ...

The ASX-listed giant says it can switch manufacturing sites if Donald Trump imposes tariffs on pharmaceuticals. It expects ...

By Christine Chen (Reuters) -Australian biopharmaceutical company CSL said on Tuesday that falling immunisation rates in the ...

This was the real deal. After I got going, I even started feeling a little dizzy and honestly I thought I might just pack it ...

The CSL Ltd (ASX: CSL) share price will be watched closely today after the biotech giant released its half year ...

CSL has reported a 7% net profit rise for the December half, with its blood-derived products offsetting weak flu vaccination ...

Bell Potter analyst Thomas Wakim maintained a Buy rating on CSL (CMXHF – Research Report) today and set a price target of A$335.00. The ...

Pharmaceuticals company CSL on Tuesday reported a 3% rise in first-half profit, benefiting from further growth in its main blood-plasma business.

Carlisle Companies Incorporated operates as a manufacturer and supplier of building envelope products and solutions in the United States, Europe, North America, Asia and the Middle East, Africa ...

In a report released today, Derek Jellinek from Morgans maintained a Buy rating on CSL (CMXHF – Research Report), with a price target of ...

CEO Paul McKenzie announced a reaffirmation of guidance for fiscal 2025, targeting NPATA growth of 10% to 13%. He highlighted strong results from CSL Behring and growth in CSL Vifor, while ...